HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer

Author： Sonpavde Guru   Wang Mingjun   Peterson Leif   Wang Helen   Joe Teresa   Mims Martha   Kadmon Dov   Ittmann Michael   Wheeler Thomas   Gee Adrian   Wang Rong-Fu   Hayes Teresa  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.32, Iss.2, 2014-04, pp. : 235-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sipuleucel-T: In Metastatic Castration-Resistant Prostate Cancer

By Plosker Greg L.  

Drugs, Vol. 71, Iss. 1, 2011-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: In Metastatic Castration-Resistant Prostate Cancer

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 2067-2077

Adis International

Access to resources Recommend Favorite

Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer

By Scott Lesley J.   Yang Lily P.H.   Lyseng-Williamson Katherine A.  

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 243-248

Adis International

Access to resources Recommend Favorite

Management of Metastatic Castration-Resistant Prostate Cancer: Recent Advances

By Mukherji Deborah   Eichholz Andrew   De Bono Johann S.  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1011-1028

Adis International

Access to resources Recommend Favorite

Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite